Ann Hanna

5PUBLICATIONS
39CO-AUTHORS
Innate immunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 10, 2025
Monitoring systemic immune responses to checkpoint inhibition in breast cancer reveals host responses and mechanisms of resistance.

Ann Hanna, Xiaopeng Sun, Quanhu Sheng

|Jan 13, 2025
In Situ Detection of Individual Classic MHC-I Gene Products in Cancer.

Paula I Gonzalez-Ericsson, Susan R Opalenik, Violeta Sanchez

|Apr 30, 2024
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer.

Elizabeth C Wescott, Xiaopeng Sun, Paula Gonzalez-Ericsson

|Oct 04, 2023
NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer.

Brandie C Taylor, Xiaopeng Sun, Paula I Gonzalez-Ericsson

|Jul 29, 2021
Breast cancer resistance mechanisms: challenges to immunotherapy.

Ann Hanna, Justin M Balko

Pageof 1

Frequent Collaborators

5 joint publications

Justin M Balko

4 joint publications

Xiaopeng Sun

3 joint publications

Brandie C Taylor

3 joint publications

Paula I Gonzalez-Ericsson